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Introduction
Pheochromocytoma is a rare tumor derived from chromaffin 
cells of the adrenal gland. It can secrete excessive catecholamine 
and cause clinical problems.1)2) Stimulation of alpha-adrenergic 
receptors results in elevated blood pressure, increased cardiac 
contractility, glycogenolysis, gluconeogenesis, and intestinal re-
laxation. Stimulation of beta-adrenergic receptors results in an 
increase in heart rate and contractility. Excessive catecholamine 
release can cause transient reversible cardiomyopathy associated 
with pheochromocytoma.3)4) There are many sporadic case re-
ports about transient episode of heart failure associated with 
pheochromocytoma. However, there is no known article about 
the incidence of cardiomyopathy in the patients with pheo-
chromocytoma. Thus we evaluated the patterns of clinical pre-
sentation and the incidence of catecholamine cardiomyopathy 
in Korean patients with pheochromocytoma. 
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Background: Excessive catecholamine release in pheochromocytoma is known to cause transient reversible left ventricular 
(LV) dysfunction, such as in the case of pheochromocytoma-associated catecholamine cardiomyopathy. We investigated patterns 
of clinical presentation and incidence of LV dysfunction in patients with pheochromocytoma. 
Methods: From January 2004 to April 2011, consecutive patients with pheochromocytoma were retrospectively studied with 
clinical symptoms, serum catecholamine profiles, and radiologic findings. Patterns of electrocardiography and echocardiography 
were also analyzed.
Results: During the study period, a total of 36 patients (21 males, 49.8 ± 15.8 years, range 14-81 years) with pheochromocytoma 
were included. In the electrocardiographic examinations, normal findings were the most common findings (19, 52.8%). LV 
hypertrophy in 12 cases (33.3%), sinus tachycardia in 3 (8.3%), ischemic pattern in 1 (2.8%) and supraventricular tachycardia in 1 
(2.8%). Echocardiographic exam was done in 29 patients (80.6%). Eighteen patients (62.1%) showed normal finding, 8 (27.6%) 
revealed concentric LV hypertrophy with normal LV systolic function, and 3 (10.3%) demonstrate LV systolic dysfunction (LV 
ejection fraction < 50%). Three showed transient LV dysfunction (2 with inverted Takotsubo-type cardiomyopathy and 1 with a 
diffuse hypokinesia pattern). Common presenting symptoms in the 3 cases were new onset chest discomfort and dyspnea which 
were not common in the other patients. Their echocardiographic abnormalities were normalized with conventional treatment 
within 3 days.
Conclusion: Out of total 36 patients with pheochromocytoma, 3 showed transient LV systolic dysfunction (catecholamine 
cardiomyopathy). Pheochromocytoma should be included as one of possible causes of transient LV systolic dysfunction.
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Methods
From January 2004 to April 2011, all consecutive patients 
with pheochromocytoma were enrolled retrospectively. Pheo-
chromocytoma was diagnosed by histologic examination after 
surgical removal. We investigated their clinical symptoms, se-
rum catecholamine profiles, urinary excretion of catechol-
amines and radiologic findings including computerized to-
mography (CT) with review of their medical records. 
The patterns of electrocardiography and echocardiography 
were also analyzed. The electrocardiographic examinations 
were performed at the time of diagnosis. Electrocardiograms 
were interpreted independently without knowledge of the 
clinical or echocardiographic finding by a specialist (J.H.K). 
Echocardiographic examinations were carried at the time of 
diagnosis and surgical removal. Complete two-dimensional, 
M-mode and Doppler studies were performed using standard 
parasternal, apical, and subcostal approaches using Vivid 7 
(GE Medical Systems, Waukesha, Wisconsin). End-diastolic 
and end-systolic LV volumes were measured in the apical four 
and two chamber view with a modified Simpson’s method. 
The LV ejection fraction was subsequently calculated. Mitral 
inflow velocities were calculated with a pulsed wave Doppler 
at the tip of the mitral valve. Mitral annular velocities were 
measured with tissue Doppler imaging of the mitral annulus. 
The calculated LV ejection fraction of less than 50% was con-
sidered the presence of LV systolic dysfunction. If there was a 
LV systolic dysfunction, a follow-up echocardiography exami-
nation was done, repeatedly.
Blood test for plasma catecholamines was done by a liquid 
chromatographic method (epinephrine less 15 pg/mL, and 
norepinephrine less than 25 pg/mL are normal in our labora-
tory).5) Urinary catecholamines were measured by a liquid 
chromatographic method and expressed as μg/24 hours (nor-
epinephrine less than 80 μg/24 hours, epinephrine less than 
22 μg/24 hours, vanillylmandelic acid less than 8 mg/24 
hours, and metanephrine less than 0.8 mg/24 hours are nor-
mal in our laboratory).5)6)  
Results
During the study period, total 36 patients (21 males, 49.8 
± 15.8 years, range 14-81 years) with pheochromocytoma 
were enrolled. Their clinical characteristics were listed in Ta-
ble 1. Most common presenting symptom was abdominal 
pain (36.1%). Nine (25.0%) of them had no clinical symp-
toms. Most common reason of detection of pheochromocyto-
ma was routine screening (17, 47.2%). Others were evalua-
tion of abdominal pain (8, 22.2%), dyspnea (4, 11.1%), 
hypertension (3, 8.3%), headache (3, 8.3%), and palpitation 
(1, 2.8%). Previous history of cardiovascular disease was rare. 
Cardiac risk factors were 47.2% with hypertension and 
16.7% with diabetes. The serum glucose level was high 
(157.8 ± 70.5 mg/dL).
All patients underwent electrocardiographic examination. 
Table 1. Characteristics of the participants
Characteristic n = 36
Male gender 21 (58.3%)
Age (year)         49.8 ± 15.8 (14-81)
Hypertension 19 (52.8%)
Diabetes   6 (16.7%)
Initial symptoms
    Abdominal pain 13 (36.1%)
    Headache 12 (33.3%)
    Chest pain   6 (16.7%)
    Palpitation   8 (22.2%)
    Sweating   9 (25.0%)
    Weight loss   7 (19.4%)
    Flushing 2 (5.6%)
    Dyspnea 2 (5.6%)
    No symptom   9 (25.0%)
CT finding
    Location of mass
        Left adrenal gland 24 (66.7%)
        Right adrenal gland 11 (30.6%)
        Bilateral adrenal glands 1 (2.7%)
    Maximal size (cm)           5.6 ± 2.8
    Cystic change 28 (77.8%)
    Hemorrhage 27 (75.0%)
Serum glucose (mg/dL)   157.8 ± 70.5 (80-321)
Blood catecholamines
    Epinephrine (pg/mL)     81.1 ± 119.0 (0.04-321.8)
    Norepinephrine (pg/mL)   286.7 ± 446.2 (1.64-1439)
Urinary catecholamine excretion
    VMA (mg/d, < 8 mg/d)      19.6 ± 22.2 (0.1-96.6) 
    Metanephrine 
      (mg/d, < 0.8 mg/d)
1278.0 ± 4059.1 (0.15-22107.4)
    Epinephrine 
      (µg/d, 1.7-22 µg/d)
  155.0 ± 334.0 (3.1-1530.6)
    Norepinephrine 
      (µg/d, 12.1-80 µg/d)
  437.3 ± 409.2 (11.9-1466.4)
Echocardiographic finding
    N/A   7 (19.4%)
    Systolic function (n = 29)
        Normal 18 (62.1%)
        LVH with normal systolic 
          function
  8 (27.6%)
        LV systolic dysfunction   3 (10.3%)
    Diastolic function (n = 29)
        Normal   7 (24.1%)
        Relaxation abnormality 22 (75.9%)
Electrocardiographic finding
    Normal 19 (52.8%)
    LVH 12 (33.3%)
    Sinus tachycardia (> 100/min) 3 (8.3%)
    Other findings 2 (5.6%)
CT: computerized tomography, VMA: vanillylmandelic acid, N/A: not 
assessed, LVH: left ventricular hypertrophyJournal of Cardiovascular Ultrasound 19 | June  2011
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Normal finding was the most common (19, 52.8%). LV hyper-
trophy was found in 12 (33.3%), sinus tachycardia (> 100/min) 
in 3 (8.3%) and other findings (2 nonspecific ST segment 
change and 1 supraventricular tachycardia) in 5.6%. Because 
there was no clinical symptoms and electrocardiographic ab-
normality, echocardiographic exam was not done in 7 patients. 
Of total 29 patients, most common finding was normal LV sys-
tolic function in 18 patients. Majority of patients (22, 75.9%) 
underwent echocardiographic examination showed relaxation 
abnormality. 
Three patients showed transient LV systolic dysfunction (2 
with inverted Takotsubo type cardiomyopathy and 1 with dif-
fuse hypokinesia pattern). Common presenting symptoms 
were new onset chest discomfort and dyspnea. However, there 
was no relationship between the presence of LV systolic dys-
function with tumor size or presence of necrosis in it. Their 
electrocardiographic examinations demonstrated sinus tachy-
cardia without evidence of ST segment change. All three pa-
tients admitted to the emergency department and cared in the 
intensive care unit. Their clinical profiles were summarized in 
the Table 2. 
Case 1
A 32-year-old man visited our emergency department with 
palpitation and squeezing chest pain. His initial blood pressure 
was 190/112 mmHg and electrocardiogram showed sinus 
tachycardia of 120/min. The initial electrocardiogram revealed 
slight ST-segment elevation in lead II, III, and aVF. Echocar-
diography demonstrated a midventricular dilatation of the LV 
and decreased LV ejection fraction of 35% (Fig. 1A and B). 
However, the motion of the LV apex was preserved. Serum lev-
els of cardiac biomarkers were increased. The serum level of N-
terminal-pro-B type natriuretic peptide (NT-pro-BNP) was in-
creased up to 733.3 pg/mL (normal range: < 200 pg/mL). The 
coronary arteries were free of any organic stenosis and LV an-
giogram showed severe hypokinesia in the mid to basal portion 
with preserved LV apical wall motion. The serum and 24-hour 
urine studies were compatible with pheochromocytoma. An 
abdominal CT showed an approximately 7.8 × 8.3 × 10.0 cm 
large septated cystic mass with irregular wall enhancement of 
the right adrenal gland and scintigraphy scan with 123I-MIBG 
showed huge round uptake in the right adrenal gland. The 
patient was treated with oral furosemide, an oral alpha blocker 
and intravenous nitrate infusion. The low dose of beta blocker 
was initiated after alpha blockade. The follow up echocardiog-
raphy after three days of treatment showed marked improve-
ment of LV systolic function and decreased LV dimension. 
The LV ejection fraction was 59%, with no regional wall mo-
tion abnormalities (Fig. 1C and D). 
Case 2
A 41-year old man presented to the emergency room due to 
new-onset dyspnea. His initial blood pressure was 180/100 
mmHg and heart rate was 140/min. The initial electrocardio-
gram demonstrated sinus tachycardia. Chest radiography 
showed pulmonary edema which improved after 3 days (Fig. 2). 
Serum levels of cardiac biomarkers were increased. NT-pro-
BNP was markedly increased up to 34,489 pg/mL. Echocar-
Table 2. Clinical profiles of the patients with transient left ventricular dysfunction
Case1 Case 2 Case 3
Gender / Age (year) Male / 32 Male / 41 Female / 49
Initial symptoms Palpitation, Chest discomfort Dyspnea Dyspnea, Chest discomfort
Initial chest X-ray finding Normal Pul edema Pul edema
Initial EchoCG finding Inverted-Takotsubo cardiomyopathy Inverted-Takotsubo cardiomyopathy Global hypokinesia
Time to normalization of EchoCG finding 3 days 3 days 3 days
Blood catecholamine
    Epinephrine (pg/mL) N/A < 15 209.2
    Norepinephrine (pg/mL) N/A < 25 299.8
Urinary catecholamine excretion
    VMA (mg/d)      31.9   41.7   25.6
    Metanephrine (mg/d) 22107.4   11.2     7.2
    Epinephrine (µg/d) 1530.6 422.2 604.1
    Norepinephrine (µg/d) 1038.8 921.0 699.6
NT-Pro BNP (pg/ mL)   733.3 34489 2458
Cardiac enzymes
    CK (U/L) 138 3606   228
    CK-MB (ng/mL)         3.84 109.3   20.5
    Troponin-I (ng/mL)         1.74     21.56     6.3
EchoCG: echocardiography, VMA: vanillylmandelic acid, NT-Pro BNP: N-terminal Pro B-type natriuretic peptide, CK: creatinine kinase, Pul edema: 
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diography showed severe LV dysfunction and a contractile ab-
normality, consisting of akinesis of the basal and mid ventricular 
segments and hyperkinesis of the apical segments (Fig. 3A 
and B). The patient was admitted at intensive care unit and 
intravenous administration of dobutamine, furosemide, and 
digoxin. His symptoms were improved in one day despite of 
sporadic surge of blood pressure and pulse rate. The 24-hour 
urine study was compatible with pheochromocytoma. The ab-
dominal CT revealed about 4.9 × 5.7 × 4.5 cm sized right ad-
renal cystic mass with hemorrhage. Follow up echocardiogra-
Fig. 1. An apical four-chamber view of the left ventricle in the emergency department is shown at end-diastole (A) and end-systole (B). At end-systole, 
mid- and basal ventricular ballooning was noted. The follow-up echocardiographic study was performed after three days of treatment. The left 
ventricular dimension was decreased and ballooning had disappeared (C at end-diastole and D at end-systole).
A
C
B
D
Fig. 2. Chest radiography shows pulmonary edema which improved after 3 days of treatment. A: On admission. B: After treatment.
A BJournal of Cardiovascular Ultrasound 19 | June  2011
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phy, repeated after two days, demonstrated normalized LV 
systolic function and regional wall motion abnormalities (Fig. 
3C and D). The elective laparoscopic right adrenalectomy was 
performed after 4 weeks of therapy including alpha and beta 
blockers. 
Case 3
A 49-year-old woman with hypertension and diabetes melli-
tus was admitted to emergency room with dyspnea and chest 
discomfort. She complained palpitation and recurrent headache 
for several months. Her initial blood pressure was 160/114 
Fig. 3. An apical four-chamber view of the left ventricle in the emergency department is shown at end-diastole (A) and end-systole (B). Apical wall 
motion is normal. However, mid- and basal ventricular ballooning is noted. The follow-up echocardiographic study performed after three days of 
treatment demonstrates decreased left ventricular size and disappeared mid- and basal ventricular ballooning (C at end-diastole and D at end-systole).
A
C
B
D
Fig. 4. Chest radiography demonstrates marked pulmonary edema which normalized after 3 days of treatment. A: On admission. B: After treatment.
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mmHg and heart rate was 100/min. The initial electrocardio-
gram demonstrated sinus tachycardia. Chest radiography 
showed marked pulmonary edema (Fig. 4). Because the patient 
showed severe hypoxemia, she was intubated and cared with 
ventilator in the intensive care unit. Her condition improved 
dramatically after 1 day and ventilator was removed after 2 
days. Cardiac enzymes were slightly elevated and NT-pro-BNP 
increased up to 2,458 pg/mL. Echocardiography showed severe 
LV systolic dysfunction with an estimated ejection fraction of 
20% and severe hypokinesia of all segments. A 24-hour urinary 
catecholamine excretion was compatible with pheochromocyto-
ma. Follow up echocardiography, repeated after two days, dem-
onstrated normalized LV systolic function and regional wall 
motion abnormalities. Cardiac catheterization was performed 
and angiographically normal epicardial coronary arteries. The 
patient was hemodynamically stabilized with conventional 
treatment. The abdominal CT scan revealed about 3.3 × 6.2 
sized tumor of the left adrenal gland and 131I-MIBG scintigra-
phy showed a hot-uptake lesion of the same location. 
Discussion
The prevalence of catecholamine cardiomyopathy associated 
with pheochromocytoma is about 10% (3 of 29 patients) in 
our study. The patterns of cardiac involvement are 2 inverted-
Takotsubo cardiomyopathies and 1 diffuse severe hypokinesia. 
All three patients showed complete recovery with inotropic 
support and conventional treatment within 3 days.
Pheochromocytomas are rare catecholamine producing tu-
mors typically located in the adrenal gland or along the sym-
pathetic ganglia. Due to secretion of catecholamines, they 
usually present with a classic triad of headache, tachycardia 
and sweating.7) 
Shub et al.8) reported echocardiographic patterns in 26 pa-
tients with pheochromocytoma. In their data, most common 
echocardiographic finding was normal or increased systolic 
function (80% of the patients). The result of our study is con-
sistent with this study. However, relaxation abnormality is the 
most common finding in our study (22, 75.8%). The increased 
incidence of diastolic dysfunction may be associated with in-
jury of myocytes or increased oxidative stress by circulating 
catecholamines.9)10) 
It has also been reported to cause cardiac manifestations in-
cluding a transient, reversible cardiomyopathy (catecholamine 
cardiomyopathy).11) Shaw et al.11) firstly reported echocardio-
graphic feature of catecholamine cardiomyopathy associated 
with pheochromocytoma in the late 1980s. It resembles Ta-
kotsubo cardiomyopathy (transient apical ballooning syndrome) 
presenting with hyperkinesis of the basal segments and apical 
hypokinesis.3)12-14) The LV systolic dysfunction usually recovers 
completely within several days. Proposed potential mecha-
nisms of transient LV ballooning include micro-vascular dys-
function of the coronary arteries, multivessel epicardial spasm, 
impaired fatty acid metabolism, myocarditis and catechol-
amine-mediated myocardial dysfunction.15)16) Although the 
mechanism of the association between sympathetic stimula-
tion and myocardial stunning is still unknown, several pro-
posed mechanisms have been proposed including coronary ar-
terial spasm17) and direct injury to myocytes.9) The apex is 
more vulnerable to a sudden increase in circulating catechol-
amine levels may be due to different distribution of sympa-
thetic nerves18) and dissimilar density of sympathetic nerves in 
the heart.19) More recently, a variant of Takotsubo cardiomyop-
athy, the ‘inverted-Takotsubo cardiomyopathy’ has been de-
scribed.15) It distinguished by dysfunction of the basal and 
mid-ventricular segments with preserved function of the api-
cal segments. Cases of inverted-Takotsubo cardiomyopathy as-
sociated with pheochromocytoma were also reported.20-22)  Two 
of our cases showed inverted-Takotsubo cardiomyopathy which 
recovered completely within 3 days. The variations in segmen-
tal involvement regardless of coronary anatomy in patients 
with excessive catecholamine levels may suggest different sus-
ceptibility to sympathetic stimulation from individual to in-
dividual.20) 
Despite this study firstly described the prevalence of tran-
sient LV systolic dysfunction with echocardiographic exami-
nation, this study has many limitations. First, this study is a 
retrospective study with review of their medical records. The 
incidence and pattern of LV systolic dysfunction could not be 
assessed exactly. However, all three patients with LV systolic 
dysfunction complained new onset dyspnea and chest discom-
fort led to visiting emergent department. Their serum NT-Pro 
BNP levels were elevated and echocardiographic examination 
revealed the presence of LV systolic dysfunction. Moreover, 9 
of total patients had no presenting symptoms suggesting pres-
ence of LV systolic dysfunction. Second, echocardiographic ex-
amination was not performed in all participants. Echocardio-
graphic examination was not performed in the patients without 
clinical symptoms and with normal electrocardiographic find-
ings (7, 19.4%). Pheochromocytoma is a very rare tumor and 
the detection is difficult especially without presenting symp-
toms. To evaluate the exact incidence and pattern of catechol-
amine cardiomyopathy associated with pheochromocytoma, 
prospective study will be needed. 
In conclusion, of total 36 patients with pheochromocytoma, 
3 showed transient LV systolic dysfunction (catecholamine 
cardiomyopathy associated with pheochromocytoma). Two of 
their echocardiographic patterns were inverted-Takotsubo car-
diomyopathy and 1 was diffuse LV hypokinesia. Their echo-
cardiographic abnormalities were normalized with conven-
tional treatment within 3 days. 
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